Substance use disorders (SUD) are common and individuals who suffer from them are prone to relapse. One of the most common consequences of the use of and withdrawal from substances of abuse is sleep disturbance. Substances of abuse affect sleep physiology, including the neurotransmitter systems that regulate the sleep-wake system. Emerging research now highlights an interactive effect between sleep disorders and substance use. New findings in alcohol and sleep research have utilized sophisticated research designs and expanded the scope of EEG and circadian rhythm analyses. Research on marijuana and sleep has progressed with findings on the effects of marijuana withdrawal on objective and subjective measures of sleep. Treatment studies have focused primarily on sleep in alcohol use disorders. Therapies for insomnia in cannabis disorders are needed. Future research is poised to further address mechanisms of sleep disturbance in alcoholics and the effect of medical marijuana on sleep and daytime functioning.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Papers of particular interest, published recently, have been highlighted as: • Of importance
Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual Causes of Death in the United States, 2000. JAMA. 2004;291(10):1238–45. doi:10.1001/jama.291.10.1238.
NIDA. Understanding Drug Abuse and Addiction. 2012.
Cohn T, Foster J, Peters T. Sequential studies of sleep disturbance and quality of life in abstaining alcoholics. Addict Biol. 2003;8:455–62.
Brower K. Alcohol's effects on sleep in alcoholics. Alcohol Res Health. 2001;25:110–25.
Roehrs T, Roth T. Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev. 2001;5(4):287–97.
Bolla K, Lesage S, Gamaldo C, Neubauer D, Funderburk F, Cadet J, et al. Sleep disturbance in heavy marijuana users. Sleep. 2008;31(6):901–8.
Colrain I, Trinder J, Swan G. The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations. Nicotine Tob Res. 2004;6:913–25.
Roehrs T, Roth T. Caffeine: Sleep and daytime sleepiness. Sleep Med Rev. 2008;12(2):153–62.
Schierenbeck T, Riemann D, Berger M, Hornyak M. Effect of illicit recreational recreational drug use upon sleep: Cocaine, ecstasy, and marijuana. Sleep Med Rev. 2008;12:381–9.
Papineau K, Roehrs T, Petrucelli N, Rosenthal L, Roth T. Electrophysiological assessment (The Multiple Sleep Latency Test) of the biphasic effects of ethanol in humans. Alcohol Clin Exp Res. 1998;22(1):231–5.
Aldrich M, Shipley J. Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res. 1993;17(1):192–6.
Aldrich MS, Brower KJ, Hall JM. Sleep-disordered breathing in alcoholics. Alcohol Clin Exp Res. 1999;23:134–40.
Rosenthal L, Roehrs T, Zwyghuizen-Doorenbos A, Plath D, Roth T. Alerting effects of caffeine after normal and restricted sleep. Neuropsychopharmacology. 1991;42(2):103–8.
Prosise G, Bonnet M, Berry R, Dickel M. Effects of abstinence from smoking on sleep and daytime sleepiness. Chest. 1994;105(4):1136–41.
Roehrs T, Papineau K, Rosenthal L, Roth T. Sleepiness and the reinforcing and subjective effects of methylphenidate. Exp Clin Psychopharmacol. 1999;7(2):145–50.
Johanson C, Roehrs T, Schuh K, Warbasse L. The effects of cocaine on mood and sleep in cocaine-dependent males. Exp Clin Psychopharmacol. 1999;7(4):338–46.
Walker J, Farney R, Rhondeau S, Boyle K, Valentine K, Cloward T, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007;3(5):455–61.
Comasco E, Nordquist N, Gokturk C, Aslund C, Hallman J, Oreland L, et al. The clock gene PER2 and sleep problems: Association with alcohol consumption among Swedish adolescents. Ups J Med Sci. 2010;115:41–8.
Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone M, et al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med. 2005;11(1):35–42.
Spanagel R, Rosenwasser A, Schumann G, Sarkar D. Alcohol consumption and the body's biological clock. Alcohol Clin Exp Res. 2005;29(8):1550–7.
Wang X, Mozhui K, Li Z, Mulligan M, Ingels J, Zhou X et al. A promoter polymorphism in the Per3 gene is associated with alcohol and stress response. Transl Psychiatry 2012;2(e73).
Clasadonte J, McIver S, Schmitt L, Halassa M, Haydon P. Chronic sleep restriction disrupts sleep homeostasis and behavioral sensitivity to alcohol by reducing the extracellular accumulation of adenosine. J Neurosci. 2014;34(5):1879–91. This study showed that chronic alcohol intake appears to induce alterations in homeostatic sleep drive in animals.
Baimel C, Bartlett S, Chiou L, Lawrence A, Muschamp J, Patkar O, et al. Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol. 2014. doi:10.1111/bph.12639.
Cahill E, Salery M, Vanhoutte P, Caboche J. Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse. Front Pharmacol. 2014;4:172. doi:10.3389/fphar.2013.00172.
Koob G. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. Curr Top Behav Neurosci. 2013;13:3–30.
Matzeu A, Zamora-Martinez E, Martin-Fardon R. The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior. Front Behav Neurosci. 2014;8:117. doi:10.3389/fnbeh.2014.00117. eCollection 2014.
Hyman S, Malenka R, Nestler E. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci. 2006;29:565–98.
Brown R, Basheer R, McKenna J, Strecker R, McCarley R. Control of sleep and wakefulness. Physiol Rev. 2012;92(3):1087–187.
Hasler B, Sitnick S, Shaw D, Forbes E. An altered neural response to reward may contribute to alcohol problems among late adolescents with an evening chronotype. Psychiatry Res. 2013;214(3):357–64.
Johnson EO, Breslau N. Sleep problems and substance use in adolescence. Drug Alcohol Depend. 2001;64(1):1–7.
Roane BM, Taylor DJ. Adolescent insomnia as a risk factor for early adult depression and substance abuse. Sleep. 2008;31(10):1351–6.
Kenney S, Paves A, Grimaldi E, Labrie J. Sleep Quality and Alcohol Risk in College Students: Examining the Moderating Effects of Drinking Motives. J Am Coll Health. 2014.
Popovici I, French M. Binge drinking and sleep problems among young adults. Drug Alcohol Depend. 2013;132(1–2):207–15.
Taylor D, Bramoweth A. Patterns and consequences of inadequate sleep in college students: Substance use and motor vehicle accidents. J Adolescents Health. 2010;46:610–2.
Zhabenko O, Krentzman A, Robinson E, Brower K. A longitudinal study of drinking and depression as predictors of insomnia ini alcohol-dependent individuals. Subst Use Misuse. 2013;48(7):495–505.
Wong M, Brower KJ, Fitzgerald H, Zucker R. Sleep problems in early childhood and early onset of alcohol and other drug use in adolescence. Alcohol: Clin Exp Res. 2004;28(4):578–87.
Wong M, Brower K. The prospective relationship between sleep problems and suicidal behavior in the National Longitudinal Study of Adolescent Health. J Psychiatr Res. 2012;46(7):953–9.
Wong M, Brower K, Nigg J, Zucker R. Childhood sleep problems, response inhibition, and alcohol and drug outcomes in adolescence and young adulthood. Alcohol Clin Exp Res. 2010;34(6):1–12.
Pasch K, Latimer L, Duncan J, Moe S, Lytle L. Longitudinal Bi-directional relationship between sleep and substance use. J Youth Adolesc. 2012;41:1184–96.
Hasler B, Martin C, Wood D, Rosario B, Clark D. A Longitudinal Study of Insomnia and Other Sleep Complaints in Adolescents With and Without Alcohol Use Disorders. Alcohol Clin Exp Res. 2014. doi:10.1111/acer.12474.
Dahl R. The impact of inadequate sleep on children’s daytime cognitive function. Semin Pediatr Neurol. 1996;3(1):44–50.
Dahl R, Lewin D. Pathways to adolescent health: Sleep regulation and behavior. J Adolesc Health. 2002;31:175–84.
Wills T, Cleary S, Filer M, Shinar O, Mariani J, Spera K. Temperament related to early-onset substance use: test of a developmental model. Prev Sci. 2001;2(3):145–63.
Hasler B, Dahl R, Holm S, Jakubcak J, Ryan N, Silk J, et al. Weekend-weekday advances in sleep timing are associated with altered reward-related brain function in healthy adolescents. Biol Psychol. 2012;91(3):334–41.
Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). Arlington, VA: American Psychiatric Publishing. 2013.
American Academy of Sleep Medicine. International Classification of Sleep Disorders 3rd Edition. Darien. 2014.
Grant B, Stinson F, Dawson D, Chou S, Dufour M, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807–16.
Huebner R, Kantor L. Advances in Alcoholism Treatment. Alcohol Res Health. 2011;33(4):295–9.
Arnedt J, Rohsenow D, Almeida A, Hunt S, Gokhale M, Gottlieb D, et al. Sleep following alcohol intoxication in healthy, young adults: effects of sex and family history of alcoholism. Alcohol Clin Exp Res. 2011;35(5):870–8.
Pressman M. Alcohol does not increase slow wave sleep. Alcohol Clin Exp Res. 2012;36(8):1474.
Pressman M, Mahowald M, Schenck C. Alcohol, sleepwalking and violence: lack of reliable scientific evidence. Brain. 2013;136(Pt 2):e229.
Wittmann M, Paulus M, Roenneberg T. Decreased psychological well-being in late 'chronotypes' is mediated by smoking and alcohol consumption. Subst Use Misuse. 2010;45(1–2):15–30.
Rupp T, Acebo C, Carskadon M. Evening alcohol suppresses salivary melatonin in young adults. Chronobiol Int. 2007;24(3):463–70.
Hasler B, Bootzin R, Cousins J, Fridel K, Wenk G. Circadian phase in sleep-disturbed adolescents with a history of substance abuse: A pilot study. Behav Sleep Med. 2008;6:55–73.
Kuhlwein E, Hauger R, Irwin M. Abnormal nocturnal melatonin secretion and disordered sleep in abstinent alcoholics. Biol Psychiatry. 2003;54(12):1437–43.
Conroy DA, Hairston IS, Arnedt JT, Hoffmann RF, Armitage R, Brower KJ. Dim light melatonin onset in alcohol-dependent men and women compared with healthy controls. Chronobiol Int. 2012;29(1):35–42. doi:10.3109/07420528.2011.636852.
Burgess H, Gorenz A, Keshavarzian A, Swanson G. Sleep and melatonin in actively drinking alcoholics. Sleep. 2014;37(Abstract supplement).
Johnston L, O’Malley P, Bachman J, Schulenberg J. Monitoring the Future national survey results on drug use, 1975-2006: Volume II, College students and adults ages 19-45. Bethesda: National Institute on Drug Abuse; 2007.
Johnston L, O’Malley P, Bachman J, Schulenberg J. Monitoring the Future national survey results on drug use, 1975-2007: Volume I, Secondary school students. Bethesda: National Institute on Drug Abuse; 2008.
Johnston L, O'Malley P, Bachman J, Schulenberg J. Monitoring the Future national survey results on drug use, 1975-2012: College students and adults ages 19-50. Ann Arbor: Institute for Social Research The University of Michigan; 2013.
Johnston L, O'Malley P, Bachman J, Shulenberg L. Monitoring the Future national survey results on drug use, 1975-2003. National Institute on Drug Abuse. 2004;1: Secondary School Students.
Bonn-Miller M, Babson K, Vandrey R. Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD. Drug Alcohol Depend. 2014;136:162–5.
Bonn-Miller M, Babson K, Vujanovic A. Sleep problems and PTSD symptoms interact to predict marijuana use coping motives. J Dual Diagn. 2010;6:111–2.
Walsh Z, Callaway R, Belle-Isle L, Caplere R, Kayf R, Lucasd P, et al. Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. Int J Drug Policy. 2013;24:511–6.
Cousins K, DiMascio A. THC as an Hypnotic: An Experimental Study of Three Dose Levels. Psychopharmacologia. 1973;33:355–64.
Nicholson AN, Turner C, Stone BM, Robson PJ. Effects of ∆–9-Tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol. 2004;24(3):305–13.
Feinberg I, Jones R, Walker JM, Cavness C, March J. Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man. Clin Pharmacol Ther. 1975;17(4):458–66.
Gillin JC, Kotin J, Post R, et al. Sleep during one week of administration of ∆-9-tetrahydrocannabinol to psychiatric patients. Sleep Res. 1972;1:44.
Barratt ES, Beaver W, White R. The effects of marijuana on human sleep patterns. Biol Psychiatry. 1974;8(1):47–54.
Conroy D, Arnedt J, Brower K, Strobbe S, Consens F, Hoffmann R, et al. Perception of sleep in recovering alcohol dependent patients with insomnia: relationship with future drinking. Alcohol Clin Exp Res. 2006;30(12):1986–99.
Colrain I, Turlington S, Baker F. Impact of alcoholism on sleep architecture and EEG power spectra in men and women. Sleep. 2009;32(19):1341–52.
Drummond S, Gillin J, Smith T, DeModena A. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res. 1998;22:1796–802.
Brower K, Hoffmann R, Conroy D, Arnedt J, Armitage R. Sleep homeostasis in alcohol-dependent, depressed and healthy control men. Eur Arch Psychiatry Clin Neurosci. 2011;261(8):559–66. doi:10.1007/s00406-011-0195-5.
Armitage R, Hoffmann R, Conroy DA, Arnedt JT, Brower KJ. Effects of a 3-hour sleep delay on sleep homeostasis in alcohol dependent adults. Sleep. 2012;35(2):273–8. doi:10.5665/sleep.1638.
de Zambotti M, Baker F, Sugarbaker D, Nicholas C, Trinder J, Colrain I. Poor Autonomic Nervous System Functioning During Sleep in Recently Detoxified Alcohol-Dependent Men and Women. Alcohol Clin Exp Res. 2014.
Amzica F, Steriade M. The K-complex: its slow (<1-Hz) rhythmicity and relation to delta waves. Neurology. 1997;49:952–9.
Colrain I, Crowley K, Nicholas C, Padilla M, Baker F. The impact of alcoholism on sleep evoked Delta frequency responses. Biol Psychiatry. 2009;66(2):177–84. This study showed that alterations in sleep physiology may occur early in abstinence.
Colrain I, Padilla M, Baker F. Partial recovery of alcohol dependence-related deficits in sleep evoked potentials following 12 months of abstinence. Front Neurol. 2012:313. This study showed that alterations in sleep physiology may occur in prolonged abstinence.
Cardenas V, Studholme C, Gardzinski S, Durazzo T, Meyerhoff D. Deformation based morphometry of brain changes in alcohol dependence and abstinence. Neuroimage. 2007;34:879–87.
O’Neill J, Cardenas V, Meyerhoff D. Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse. Alcohol Clin Exp Res. 2001;25:1673–82.
Pfefferbaum A, Sullivan E, Mathalon D, Shear P, Rosenbloom M, Lim K. Longitudinal changes inmagnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res. 1995;19:1177–91.
Babson K, Boden M, Bonn-Miller M. The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt. Addict Behav. 2013;38:2707–13.
Babson K, Boden M, Bonn-Miller M. Sleep quality moderates the relation between depression symptoms and problematic cannabis use among medical cannabis users. Am Drug Alcohol Abus. 2013;39(3):211–6. This study was the first to show that poor sleep quality and low mood negatively impacts ability quit marijuana use.
Babson K, Boden M, Harris A, Stickle T, Bonn-Miller M. Poor sleep quality as a risk factor for lapse following a cannabis quit attempt. J Subst Abus Treat. 2013;44:438–43. This study was the first to show that poor sleep quality negatively impacts ability quit marijuana use.
Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112(3):393–402.
Budney A, Hughes J, Moore B, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004;161(11):1967–77.
Copersino M, Boyd S, Tashkin D, Huestis M, Heishman S, Dermand J. Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. Am J Addict. 2006;15(4):297–302.
Bolla K, Lesage S, Gamaldo C, Neubauer D, Wang N, Funderburk F, et al. Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence. Sleep Med. 2010;11(9):882–9.
Haney M, Hart C, Vosburg S, Comer S, Reed S, Foltin R. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology. 2008;197(1):157–68.
Budney AJ, Hughes JR, Moore BA, Novy PL. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry. 2001;58(10):917–24.
Brower KJ. Insomnia, alcoholism and relapse. Sleep Med Rev. 2003;7(6):523–39.
Howland R. Gabapentin for Substance Use Disorders: Is it Safe and Appropriate? J Psychosoc Nurs Ment Health Serv. 2014:1-4.
Brower K, Kim HM, Strobbe S, Karam-Hage M, Consens F, Zucker R. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res. 2008;32(8):1–10.
Friedmann P, Rose J, Swift R, Stout R, Millman R, Stein M. Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial. Alcohol Clin Exp Res. 2008;32(9):1652–60.
Anton R, Myrick H, Wright T, Latham P, Baros A, Waid L, et al. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011;168(7):709–17.
Monnelly E, Ciraulo D, Knapp C, LoCastro J, Sepulvda I. Quetiapine for treatment of alcohol dependence. J Clin Psychopharmacol. 2004;24:532–5.
Chakravorty S, Hanlon A, Kuna S, Ross R, Kampman K, Witte L et al. The Effects of Quetiapine on Sleep in Recovering Alcohol-Dependent Subjects: A Pilot Study. J Clin Psychopharmacol. 2014.
Brower K, Conroy D, Kurth M, Stein M. Ramelteon and Improved Insomnia in Alcohol-Dependent Patients: A Case Series. J Clin Sleep Med. 2011;7(3):274–5.
Grosshans M, Mutschler J, Luderer M, Mann K, Kiefer F. Agomelatine is effective in reducing insomnia in abstinent alcohol-dependent patients. Clin Neuropharmacol. 2014;37(1):6–8.
Currie SR, Clark S, Hodgins DC, el-Guebaly N. Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcohlics. Addiction. 2004;99:1121–32.
Arnedt JT, Conroy D, Rutt J, Aloia MS, Brower KJ, Armitage R. An open trial of cognitive-behavioral treatment for insomnia comorbid with alcohol dependence. Sleep Med. 2007;8(2):176–80.
Arnedt J, Conroy D, Armitage R, Brower K. Cognitive-behavioral therapy for insomnia in alcohol dependent patients: a randomized controlled pilot trial. Behav Res Ther. 2011;49(4):227–33.
Compliance with Ethics Guidelines
Conflict of Interest
Deirdre A. Conroy and J. Todd Arnedt declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
This article is part of the Topical Collection on Sleep Disorders
About this article
Cite this article
Conroy, D.A., Arnedt, J.T. Sleep and Substance Use Disorders: An Update. Curr Psychiatry Rep 16, 487 (2014). https://doi.org/10.1007/s11920-014-0487-3
- Sleep latency (SL)
- Wake after sleep onset (WASO)
- Total sleep time (TST)
- Sleep efficiency (SE; TST/time between “lights out” and “lights on”)
- Percentages of stages 1 (S1%), 2 (S2%), 3 (S3%), 4 (S4%), Slow wave activity (SWA)
- Slow wave sleep (SWS%)
- Rapid eye movement (REM%) Sleep
- REM latency (REM-L; duration between “sleep onset” and “REM onset”)